Breaking News Instant updates and real-time market news.

BEL

Belmond

$17.99

-0.18 (-0.99%)

, HLT

Hilton

$77.32

-1.08 (-1.38%)

16:02
10/02/18
10/02
16:02
10/02/18
16:02

Belmond said to attract interest from Hilton and PE firms, Bloomberg says

Belmond (BEL) has attracted takeover interest from both strategic and financial suitors who may be interested in making offers for all or part of the company, including KKR (KKR), Blackstone (BX), Hilton (HLT) and Hyatt (H), according to Bloomberg, citing sources.

BEL

Belmond

$17.99

-0.18 (-0.99%)

HLT

Hilton

$77.32

-1.08 (-1.38%)

H

Hyatt

$77.68

-1.26 (-1.60%)

KKR

KKR

$27.50

0.005 (0.02%)

BX

Blackstone

$38.54

-0.23 (-0.59%)

  • 02

    Oct

  • 31

    Oct

BEL Belmond
$17.99

-0.18 (-0.99%)

08/10/18
DBAB
08/10/18
NO CHANGE
Target $17
DBAB
Hold
Belmond price target raised to $17 from $11 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Belmond to $17 after the company said it would explore strategic alternatives. The consensus view at this point on the outcome of the process has pivoted toward an outright sale of the company, Santarelli tells investors in a research note. He keeps a Hold rating on Belmond.
08/10/18
JEFF
08/10/18
UPGRADE
Target $20
JEFF
Buy
Belmond upgraded to Buy from Hold at Jefferies
Jefferies analyst David Katz upgraded Belmond to Buy and raised his price target for the shares to $20 from $13. With the company reviewing strategic alternatives, the analyst shifted the balance of his valuation perspective from the operating productivity to asset market value. Katz sees a high probability of a sale of Belmond given the quality of the company's assets. He believes such a deal could drive further upside in the stock.
08/09/18
JEFF
08/09/18
NO CHANGE
Target $13
JEFF
Hold
Belmond should rally 'sharply' on strategic review, says Jefferies
Jefferies analyst David Katz expects Belmond shares "to be up sharply" on news that the company will explore strategic alternatives. The analyst reiterates his view that the market value of Belmond's underlying assets is considerably higher than that which the earnings potential of the company could support. He keeps a Hold rating on the stock with a $13 price target. Belmond in premarket trading is up 26% to $14.05.
08/17/18
LEHM
08/17/18
NO CHANGE
Target $11
LEHM
Underweight
Belmond price target raised to $15, remains Underweight at Barclays
Barclays analyst Felicia Hendrix believes Belmond management is serious about exploring all available avenues to enhance shareholder value, including a potential sale. However, Hendrix said a scenario that does not result in a sale could result in downside and believes some shareholders may benefit from locking in some gains now given the A/B share structure. The analyst increased her net asset value estimate for Belmond to $18 from $17 and raised her price target on shares to $15 from $11, but maintains an Underweight rating especially given high expectations for the value of Belmond's real estate.
HLT Hilton
$77.32

-1.08 (-1.38%)

09/07/18
LBOW
09/07/18
INITIATION
Target $96
LBOW
Buy
Hilton initiated with a Buy at Longbow
Longbow analyst Alton Stump initiated Hilton with a Buy and $96 price target given accelerating RevPAR growth, potential accelerating net room count growth, and a favorable economic landscape.
08/28/18
RHCO
08/28/18
INITIATION
Target $14
RHCO
Buy
Playa Hotels & Resorts initiated with a Buy at SunTrust
SunTrust analyst C. Patrick Scholes initiated Playa Hotels & Resorts with a Buy rating and a price target of $14, saying the company's growth strategy through and beyond 20201 is "highly compelling". The analyst sees annualized adjusted EBITDA growth through 2021 at 15% or more, which is the highest growth rate in the period across his hotel coverage group. Scholes adds that leisure demand has been strong, with an increase in consumer interest toward the "high-quality all-inclusive resorts" and notes that Playa Hotels may become the "first adopter of an all-inclusive brand from Hilton (HLT) and/or Marriott (MAR)" in the near future.
08/17/18
BERN
08/17/18
DOWNGRADE
BERN
Market Perform
Hilton downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst David Beckel downgraded Hilton (HLT) to Market Perform from Outperform, telling investors that Hilton's current valuation fairly reflects his expectation of an environment in which U.S. RevPAR and unit growth decelerate over the next 12 months, potentially faster than currently forecast. He expects a combination of slowing growth and a lack of catalysts will limit upside for both Hilton and Market Perform-rated Marriott (MAR) during that time.
08/16/18
BERN
08/16/18
DOWNGRADE
BERN
Market Perform
Hilton downgraded to Market Perform from Outperform at Bernstein
H Hyatt
$77.68

-1.26 (-1.60%)

09/07/18
LBOW
09/07/18
INITIATION
Target $99
LBOW
Buy
Hyatt initiated with a Buy at Longbow
Longbow analyst Alton Stump initiated Hyatt with a Buy and $99 price target given accelerating RevPAR growth, impressive net room count growth, and favorable economic landscape.
06/12/18
NOMU
06/12/18
NO CHANGE
Target $105
NOMU
Buy
Nomura raises price targets in Lodging, sees most upside in Hilton
Nomura Instinet analyst Harry Curtis raised his Lodging sector price targets after rolling forward his estimates to 2019 EBITDA. The analyst sees the most upside in his Buy-rated stocks: Hilton (HLT), Marriott (MAR), Hilton Grand Vacations (HGV), Extended Stay America (STAY) and Playa Hotels & Resorts (PLYA). He raised his price target for Neutral-rated Choice Hotels (CHH) to $88 from $85, Neutral-rated Hyatt (H) to $85 from $76, Hilton Grand Vacations to $52 from $50, Hilton to $105 from $99, Neutral-rated Host Hotels (HST) to $23 from $22 and Marriott to $165 from $159.
07/19/18
07/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Hold at Needham with analyst Rajvindra Gill saying the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at UBS with analyst Steven Strycula saying the company's reinvestment cycle limits earnings and stock upside. 3. Terex (TEX) downgraded to Market Perform from Outperform at Wells Fargo with analyst Andrew Casey saying his crane check was good but not great, with demand appearing to sequentially flatten. 4. Spark Therapeutics (ONCE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Kennen MacKay saying that after a strong run-up in the stock price driven by lofty expectations for the ongoing Phase 1/2 trial of SPK-8011 in patients with hemophilia, achieving mean FVIII expression levels of 30-55% anticipated by the Street could prove "challenging" as "data to date has not indicated clear dose responsiveness." 5. Hyatt (H) downgraded to Hold from Buy at Berenberg with analyst El Kassir saying Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
BREN
07/19/18
DOWNGRADE
BREN
Hold
Hyatt downgraded to Hold from Buy at Berenberg
Berenberg analyst El Kassir downgraded Hyatt to Hold and raised his price target to $87.50 from $83 following 10% outperformance since his upgrade. Kassir said Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. Further, the analyst believes that property disposals may moderate from here or alternative investments versus returning cash to shareholders.
KKR KKR
$27.50

0.005 (0.02%)

07/10/18
SBSH
07/10/18
NO CHANGE
Target $31
SBSH
Buy
KKR price target raised to $31 from $28 at Citi
Citi analyst William Katz raised his price target for KKR to $31 and keeps a Buy rating on the shares following the company's investor day. The analyst believes KKR's conversion to a corporation has created a "favorable feedback loop for the sector."
07/10/18
WELS
07/10/18
NO CHANGE
Target $30
WELS
Outperform
KKR price target raised to $30 from $25 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for KKR to $30 from $25 after attending the company's Investor Day and as he believes the outlook appears to remain quite promising. The analyst reiterates an Outperform rating on the shares.
08/22/18
WELS
08/22/18
UPGRADE
Target $22
WELS
Outperform
KKR Real Estate Finance upgraded to Outperform with $22 target at Wells Fargo
Wells Fargo analyst Donald Fandetti upgraded KKR Real Estate Finance (KREF) to Outperform from Market Perform and raised his price target for the shares to $22 from $20. The company is gaining traction through leveraging KKR (KKR) for both originations and unique financing vehicles, Fandetti tells investors in a research note. Further, he sees multiple expansion for the commercial mortgage REITs as "equity markets catch up with spread tightening in the debt markets." In addition, lending markets are "healthy" despite the rise in 10-year U.S. Treasury yields, Fandetti contends.
09/14/18
MSCO
09/14/18
NO CHANGE
Target $42
MSCO
Overweight
Morgan Stanley says Blackstone valuation gap with KKR unjustified
With KKR (KKR) up 41% in the last twelve months, the shares of Blackstone (BX) are now trading at their lowest relative valuation to the former, which Morgan Stanley analyst Michael Cyprys said he views as unjustified. He attributes a mix of C-corp conversion, CRSP index inclusion, and strong asset gathering and fee growth at KKR for the strength, but also believes Blackstone's upcoming investor day on September 21 could be a catalyst to fix the "valuation disconnect." While he doesn't expect a C-corp conversion announcement in the near-term, Cyprys wouldn't be surprised to see Blackstone follow KKR's lead and shift toward a cash earnings approach from reporting on a more volatile mark to market basis, he tells investors. The analyst, who could see a $50 valuation for Blackstone if the stock re-rates to its historical premium to KKR, keeps an Overweight rating and $42 price target on Blackstone shares.
BX Blackstone
$38.54

-0.23 (-0.59%)

09/24/18
SBSH
09/24/18
NO CHANGE
Target $47.5
SBSH
Buy
Blackstone price target raised to $47.50 from $43 at Citi
Citi analyst William Katz raised his price target for Blackstone to $47.50 following last week's investor day. The analyst left constructive on the Alternatives sector and impressed by the "multitude of earnings drivers" at Blackstone. He's encouraged by the company's "growing competitive moat and longer-term opportunities" and keeps a Buy rating on the shares.
09/24/18
MSCO
09/24/18
NO CHANGE
Target $48
MSCO
Overweight
Blackstone price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he came away from Blackstone's investor day more positive on the company's superior AUM and fee growth and ability to innovate. Blackstone also said a C-Corp conversion is under active consideration, which is a more positive stance than in it has expressed in the past, Cyprys tells investors. Based on expectations for strong growth in AUM, management fees and performance fee, along with the rising prospects for C-Corp conversion, Cyprys raised his price target on Blackstone shares to $48 from $42 and keeps an Overweight rating on the stock.
09/24/18
JMPS
09/24/18
NO CHANGE
Target $43
JMPS
Outperform
Blackstone price target raised to $43 after investor day at JMP Securities
JMP Securities analyst Devin Ryan raised his price target on Blackstone shares to $43 from $39 following the company's investor day, from which he said the primary takeaway was the company's detailed roadmap for growth to $1T+ of AUM over the next eight years from $439B of total assets today. Ryan, who said Blackstone communicated a "clear line of sight" into $2 of fee-related earnings over the longer-term, keeps an Outperform rating on Blackstone shares.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.

TODAY'S FREE FLY STORIES

MNSB

MainStreet Bancshares

$0.00

(0.00%)

11:42
02/21/19
02/21
11:42
02/21/19
11:42
Hot Stocks
MainStreet Bancshares applies to list common stock on NASDAQ Capital Market »

MainStreet Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZSAN

Zosano Pharma

$4.19

1.98 (89.59%)

11:40
02/21/19
02/21
11:40
02/21/19
11:40
Recommendations
BTIG boosts Zosano target to $19 on 'solid' migraine safety data »

BTIG analyst Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:38
02/21/19
02/21
11:38
02/21/19
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
02/21/19
02/21
11:38
02/21/19
11:38
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

UNIT

Uniti Group

$11.23

-1.035 (-8.44%)

11:35
02/21/19
02/21
11:35
02/21/19
11:35
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 11

    Mar

  • 11

    Mar

ZSAN

Zosano Pharma

$3.89

1.68 (76.02%)

11:32
02/21/19
02/21
11:32
02/21/19
11:32
Hot Stocks
Breaking Hot Stocks news story on Zosano Pharma »

Zosano Pharma jumps 100%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Conference/Events
UBS leisure/lodging analyst to hold an analyst/industry conference call »

Leisure, Gaming &…

ZSAN

Zosano Pharma

$3.89

1.68 (76.02%)

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Hot Stocks
Zosano says Qtrypta long-term study shows 'well-tolerated safety profile' »

Zosano Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$4.85

-0.05 (-1.02%)

11:31
02/21/19
02/21
11:31
02/21/19
11:31
Hot Stocks
Zynerba patent listed by World Intellectual Property Organization »

The patent listed by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$24.23

-0.45 (-1.82%)

11:25
02/21/19
02/21
11:25
02/21/19
11:25
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 04

    Mar

  • 20

    Mar

KMTUY

Komatsu

$0.00

(0.00%)

11:21
02/21/19
02/21
11:21
02/21/19
11:21
Downgrade
Komatsu rating change  »

Komatsu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
02/21/19
02/21
11:20
02/21/19
11:20
General news
Treasury announced $113 B in shorter dated coupon sales for next week »

Treasury announced $113 B…

SCI

Service Corp.

$42.31

-0.42 (-0.98%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Hot Stocks
Service Corp. raises quarterly cash dividend 6% to 18c per share »

Service Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
02/21/19
02/21
11:16
02/21/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

GS

Goldman Sachs

$197.12

-1.49 (-0.75%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Initiation
Goldman Sachs initiated  »

Odeon's Dick Bove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

  • 12

    Mar

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DK

Delek US

$36.95

-0.13 (-0.35%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Options
Delek US draws upside call buyers as shares slip off early highs »

Delek US draws upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Existing home sales fell 1.2% in January to 4.99 M, a 3-year low »

Existing home sales fell…

11:08
02/21/19
02/21
11:08
02/21/19
11:08
General news
3-Month Bill Announcement CUSIP Number data reported »

3-Month Bill Announcement…

MNST

Monster Beverage

$58.64

-0.07 (-0.12%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Options
Monster Beverage option volume spikes to 3X daily average amid active trading »

Monster Beverage option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

LIVN

LivaNova

$98.56

-1.32 (-1.32%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Recommendations
LivaNova analyst commentary  »

Piper says Japanese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 07

    May

  • 08

    May

  • 09

    May

UBCP

United Bancorp

$10.95

(0.00%)

11:04
02/21/19
02/21
11:04
02/21/19
11:04
Hot Stocks
United Bancorp raises quarterly cash dividend to 13.25c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.